These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15230340)

  • 1. The interaction of the diltiazem with oral and intravenous cyclosporine in rats.
    Kalkan S; Gumustekin M; Aygoren O; Tuncok Y; Gelal A; Guven H
    Eur J Drug Metab Pharmacokinet; 2004; 29(2):119-23. PubMed ID: 15230340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].
    Liu XL; Tang J; Song J; He J; Xu P; Peng WX
    Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of combined oral treatments with cyclosporine A and nifedipine or diltiazem on drug-induced gingival overgrowth in rats.
    Morisaki I; Fukui N; Fujimori Y; Murakami J; Daikoku H; Amano A
    J Periodontol; 2000 Mar; 71(3):438-43. PubMed ID: 10776932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a beneficial effect of the calcium channel blocker diltiazem on cyclosporine A nephrotoxicity in rats?
    Kuhn UD; Lupp A; Kostka E; Kühl A; Balogh A; Stein G; Fleck C
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):484-90. PubMed ID: 9784027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of factors to decrease bioavailability of cyclosporin A in rats with gentamicin-induced acute renal failure.
    Shibata N; Inoue Y; Fukumoto K; Nishimura A; Fukushima K; Yoshikawa Y; Spiteller G; Takada K
    Biol Pharm Bull; 2004 Mar; 27(3):384-91. PubMed ID: 14993807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision support tool to individualize cyclosporine dose in stable, long-term heart transplant recipients receiving metabolic inhibitors: overcoming limitations of cyclosporine C2 monitoring.
    Ray JE; Keogh AM; McLachlan AJ
    J Heart Lung Transplant; 2006 Oct; 25(10):1223-9. PubMed ID: 17045935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
    Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
    Li C; Choi JS
    Pharmazie; 2008 Nov; 63(11):815-8. PubMed ID: 19069242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diltiazem does not always increase blood cyclosporin concentration.
    Jones TE; Morris RG
    Br J Clin Pharmacol; 1996 Nov; 42(5):642-4. PubMed ID: 8951199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Hong SP; Chang KS; Choi DH; Choi JS
    Arch Pharm Res; 2007 Jan; 30(1):90-5. PubMed ID: 17328247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
    Bunnag S; Vareesangthip K; Ong-ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S228-34. PubMed ID: 17044476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients.
    Bleck JS; Thiesemann C; Kliem V; Christians U; Hecker H; Repp H; Frei U; Westhoff-Bleck M; Manns M; Sewing KF
    Br J Clin Pharmacol; 1996 Jun; 41(6):551-6. PubMed ID: 8799521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-course effects of St John's wort on the pharmacokinetics of cyclosporine in dogs: interactions between herbal extracts and drugs.
    Fukunaga K; Orito K
    J Vet Pharmacol Ther; 2012 Oct; 35(5):446-51. PubMed ID: 22091645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of co-administration of diltiazem and cyclosporine in Chinese kidney transplant recipients.
    Xue W; Ding X; Tian P; Pan X; Yan H; Hou J; Feng X; Xiang H; Tian X
    Ren Fail; 2010 Jan; 32(3):314-9. PubMed ID: 20370446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of cyclosporin-A pharmacokinetics after experimental spinal cord injury.
    Ibarra A; Guízar-Sahagún G; Correa D; Kretschmer R; Grijalva I; Flores-Murrieta FJ; Castañeda-Hernández G; Odor A; López RM; Franco-Bourland R; Espitia AL; Salgado-Ceballos H; Madrazo I
    J Neurotrauma; 1996 May; 13(5):267-72. PubMed ID: 8797176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of cyclosporine after intravenous and multi-dose oral administration in cats.
    Mehl ML; Kyles AE; Craigmill AL; Epstein S; Gregory CR
    J Vet Pharmacol Ther; 2003 Oct; 26(5):349-54. PubMed ID: 14633187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin C(2) and C(0) concentration monitoring in stable, long-term heart transplant recipients receiving metabolic inhibitors.
    Ray JE; Keogh AM; McLachlan AJ; Akhlaghi F
    J Heart Lung Transplant; 2003 Jul; 22(7):715-22. PubMed ID: 12873538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bioavailability and metabolism with two commercial formulations of cyclosporine a in rats.
    Koehler J; Kuehnel T; Kees F; Hoecherl K; Grobecker HF
    Drug Metab Dispos; 2002 Jun; 30(6):658-62. PubMed ID: 12019192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.